iShares Neuroscience and Healthcare ETF (IBRN)

Assets	$3.53M
Expense Ratio	0.47%
PE Ratio	n/a
Shares Out	150,000
Dividend (ttm)	$0.01
Dividend Yield	0.06%
Ex-Dividend Date	Dec 20, 2023
Payout Ratio	n/a
1-Year Return	-1.47%

Volume	2,425
Open	23.54
Previous Close	23.58
Day's Range	23.54 - 23.75
52-Week Low	19.08
52-Week High	26.90
Beta	1.07
Holdings	61
Inception Date	Aug 24, 2022

About IBRN

Fund Home Page

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is issued by BlackRock.

• Asset Class: Equity
• Region: Global
• Stock Exchange: NYSEARCA
• Ticker Symbol: IBRN
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Neuro Biopharma and MedTech Index

Top 10 Holdings

42.55% of assets

Name	Symbol	Weight
Sarepta Therapeutics, Inc.	SRPT	5.03%
argenx SE	ARGX	4.65%
Dyne Therapeutics, Inc.	DYN	4.49%
ACADIA Pharmaceuticals Inc.	ACAD	4.32%
Biohaven Pharmaceutical Holding Company Ltd.	BHVN	4.10%
Intra-Cellular Therapies, Inc.	ITCI	4.07%
Alkermes plc	ALKS	3.99%
Biogen Inc.	BIIB	3.99%
Cerevel Therapeutics Holdings, Inc.	CERE	3.97%
Axonics, Inc.	AXNX	3.94%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 20, 2023	$0.0063	Dec 27, 2023
Jun 7, 2023	$0.00824	Jun 13, 2023